ID   SNUe003-A-3
AC   CVCL_A0MK
SY   SNUhES3-alphaMHC-EGFP; A-eG-KI-SE-3; IRMPe004-A-3
DR   BioSamples; SAMEA9403864
DR   hPSCreg; SNUe003-A-3
DR   Wikidata; Q108821319
RX   PubMed=35427904;
CC   From: Seoul National University; Seoul; South Korea.
CC   Population: Korean.
CC   Characteristics: Using CRISPR/Cas9 a T2A-EGFP-polyA-PGKp-PuroR-polyA construct was introduced at the C-terminus of MYH6 (PubMed=35427904).
CC   Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP).
CC   Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9949 ! SNUhES3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 7
//
RX   PubMed=35427904; DOI=10.1016/j.scr.2022.102779;
RA   Lee H.M., Kim A.-H., Hwang S., Jung J., Seol H., Sung J.J., Jeong S.M.,
RA   Choi Y.M., Jun J.K., Kim H.-S., Jang J.;
RT   "Generation of alphaMHC-EGFP knock-in in human pluripotent stem cell
RT   line, SNUe003-A-3 using CRISPR/Cas9-based gene targeting.";
RL   Stem Cell Res. 61:102779-102779(2022).
//